Charbel Alhelou Arcascience
Charbel Alhelou – PharmD, MBA, and M2R
Charbel Alhelou is a Doctor of Pharmacy with master’s degrees in Clinical and Preclinical Pharmacology, Research in Pharmacoepidemiology, and Business Administration.
He has contributed to various research projects, including a study on the impact of SGLT2 inhibitors on atrial fibrillation.
With four years of experience in community pharmacy, Charbel has developed a deep understanding of patient needs, effective communication, and the value of diverse perspectives in healthcare.
Currently, as a Product Manager at Arcascience, he focuses on leveraging AI to address critical challenges in the pharmaceutical industry. Over the past 18 months, Charbel has led the Benefit-Risk Assessment Project, integrating advanced technologies and emphasizing patient-centric approaches to support drug development.